Avigail Rein

465 citations
6 papers · 289 indexed · h-index 5
Topics
Virus-based gene therapy research (2 papers)Herpesvirus Infections and Treatments (2 papers)Epigenetics and DNA Methylation (2 papers)
Partner nations
IsraelUnited StatesChina

In The Last Decade

Avigail Rein

6 papers receiving 287 citations

Peers

Avigail Rein
Comparison fields: 5 of 47
  • Psychiatry and Mental health 102
  • Oncology 101
  • Molecular Biology 95
  • Cellular and Molecular Neuroscience 71
  • Neurology 44
Replace Anastasie Dunn‐Pirio with:
Anastasie Dunn‐Pirio United States
Ide Smets Belgium
Seiichi Odate Japan
Sandra Cappellacci Italy
Jun Yoshida Japan
Katrin S. Kurz Germany
Shireena A. Yasin United Kingdom
Naga Pradyumna Kothapalli United States
Sebastian Herich Germany
Dan Whittam United Kingdom
Avigail Rein relative to Anastasie Dunn‐Pirio United States Anastasie Dunn‐Pirio's profile →
Citations per field
00.5×6.3×
Anastasie Dunn‐Pirio · 1×
Citations per year

Countries citing papers authored by Avigail Rein

Since Specialization
Citations

This map shows the geographic impact of Avigail Rein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Avigail Rein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Avigail Rein more than expected).

Fields of papers citing papers by Avigail Rein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Avigail Rein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Avigail Rein. The network helps show where Avigail Rein may publish in the future.

Co-authorship network of co-authors of Avigail Rein

This figure shows the co-authorship network connecting the top 25 collaborators of Avigail Rein. A scholar is included among the top collaborators of Avigail Rein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Avigail Rein. Avigail Rein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
#WorkIndexed citations
1 9
2 1
3 29
4 196
5 15
6 39

About Avigail Rein

Avigail Rein is a scholar working on Hematology, Genetics and Genetics, having authored 6 papers that have together received 289 indexed citations. Recurring topics across this work include Virus-based gene therapy research (2 papers), Herpesvirus Infections and Treatments (2 papers) and Epigenetics and DNA Methylation (2 papers). The work is most often cited by research in Psychiatry and Mental health (102 citations), Cellular and Molecular Neuroscience (71 citations) and Oncology (101 citations). Avigail Rein has collaborated with scholars based in Israel, United States and China. Frequent co-authors include Peter Brader, Ziv Gil, Yuman Fong, Richard J. Wong, Jatin P. Shah, Kaitlyn J. Kelly, Oren Cavel, Sizhi Paul Gao, Diane L. Carlson and Sen Li. Their work appears in journals such as Blood, JNCI Journal of the National Cancer Institute and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026